This is why we invested in MNKD for these moments
Aug 29, 2019 17:36:13 GMT -5
goyocafe, sportsrancho, and 20 more like this
Post by mannmade on Aug 29, 2019 17:36:13 GMT -5
As an investor in Mnkd since 2008, I likely now (as most on this board) know too much about Afrezza for my own good...
I have been on Metformin prescribed by my PCP prophylactically for over 5 years now. My last a1c was 5.9, so I decided to see an endo today, (whose name I will not mention and the appt only took a week to get btw.) I suppose I could control my a1c by working out or eating better. However, as a former competitive athlete I just dont want to keep up in the gym after all the years. And frankly, like Spiro my weakness is carbs and peanut M&M's (to Spiro's Malomars.)
My endo is part of a very large medical group with at least three good sized offices all located in different parts of the San Fernando Valley in California. The endo wing was a large part of the practice so I am assuming they have quite a few endo patients. Each office has an Endo dept.
She is young, likely in her mid 30's and very knowledgeable. When I asked her if she knew of Afrezza she replied she did. When I asked her if she would prescribe it to me she wanted to know why I was so interested in being on insulin even if I was pre-diabetic, which she was not yet sure I was. I told here there were studies that showed early adoption in T2's may prevent the further deterioration of Beta cells.
She said that it may be true, but that there were so many good options before going on insulin these days and that generally T2's were started on basil first if eventually they went to insulin. I then explained that I understood that basil on T2's was because prior to Afrezza it was more convient for a T2 on insulin to take one shot per day than multiple shots and that RAA's caused too many hypos which Afrezza does not. She did not disagree but did say that again insulin would not be her first choice for a T2.
As our discussion went on, she was persistent in telling me that she would not prescribe it to me for now. We instead agreed that I would continue to monitor and keep a record of my BG and see where we are in 6 months and 12 months after she could better understand my health history and situation regarding my a1c. I had just purchased a one drop kit from Apple and so she did write a script for one drop supplies for me to create and maintian such a history.
So I finally asked her before I left if she had any patients on Afrezza and her response was... "Oh yes! Many."
My conslusion is that Afrezza is slowly gaining acceptance, at least with the younger newer endos, but it is still viewed in many ways similar to RAA insulins and the learning curve for both doctors and PWD is continuing. But I am encouraged.
I have been on Metformin prescribed by my PCP prophylactically for over 5 years now. My last a1c was 5.9, so I decided to see an endo today, (whose name I will not mention and the appt only took a week to get btw.) I suppose I could control my a1c by working out or eating better. However, as a former competitive athlete I just dont want to keep up in the gym after all the years. And frankly, like Spiro my weakness is carbs and peanut M&M's (to Spiro's Malomars.)
My endo is part of a very large medical group with at least three good sized offices all located in different parts of the San Fernando Valley in California. The endo wing was a large part of the practice so I am assuming they have quite a few endo patients. Each office has an Endo dept.
She is young, likely in her mid 30's and very knowledgeable. When I asked her if she knew of Afrezza she replied she did. When I asked her if she would prescribe it to me she wanted to know why I was so interested in being on insulin even if I was pre-diabetic, which she was not yet sure I was. I told here there were studies that showed early adoption in T2's may prevent the further deterioration of Beta cells.
She said that it may be true, but that there were so many good options before going on insulin these days and that generally T2's were started on basil first if eventually they went to insulin. I then explained that I understood that basil on T2's was because prior to Afrezza it was more convient for a T2 on insulin to take one shot per day than multiple shots and that RAA's caused too many hypos which Afrezza does not. She did not disagree but did say that again insulin would not be her first choice for a T2.
As our discussion went on, she was persistent in telling me that she would not prescribe it to me for now. We instead agreed that I would continue to monitor and keep a record of my BG and see where we are in 6 months and 12 months after she could better understand my health history and situation regarding my a1c. I had just purchased a one drop kit from Apple and so she did write a script for one drop supplies for me to create and maintian such a history.
So I finally asked her before I left if she had any patients on Afrezza and her response was... "Oh yes! Many."
My conslusion is that Afrezza is slowly gaining acceptance, at least with the younger newer endos, but it is still viewed in many ways similar to RAA insulins and the learning curve for both doctors and PWD is continuing. But I am encouraged.